Combined PRP and CCP Therapy Suppresses Inflammation and Protects Cartilage in Post-Traumatic Osteoarthritis.

Overview

• This research investigates the effects of combining platelet-rich plasma (PRP) and Cervus and Cucumis polypeptide (CCP) injections to treat post-traumatic osteoarthritis (OA) in a rat model.
• The study assesses whether this combined therapy can reduce inflammation, protect cartilage, improve joint function, and relieve pain associated with OA.

Purpose and Background

• Post-traumatic osteoarthritis (OA) is a common condition following joint injuries, characterized by inflammation, cartilage degradation, joint pain, and impaired mobility.
• Current treatments often focus on pain relief but do not fully halt cartilage degeneration or restore joint health.
• Platelet-rich plasma (PRP) is rich in growth factors and has been used to promote tissue healing and reduce inflammation in joint disorders.
• Cervus and Cucumis polypeptide (CCP) are bioactive compounds thought to have anti-inflammatory and cartilage-protective properties.
• The study aims to assess the therapeutic potential of PRP combined with CCP in improving symptoms and joint condition after ligament injury-induced OA in rats.

Methodology

• OA model induction: Rats underwent transection of the anterior cruciate ligament (ACL), a surgical procedure that simulates post-traumatic OA by destabilizing the knee joint.
• Treatment groups: Following OA induction, rats received injections of either PRP, CCP, or a combination of both to evaluate their effects.
• Assessment techniques included:
  • Gross morphological observation of the joint cartilage to visually assess cartilage damage.
  • Histopathological staining to examine cartilage and surrounding tissues microscopically.
  • Use of a standardized scoring system to quantify cartilage degeneration severity.
  • Measurement of pain-related behaviors to assess functional improvement.
  • Evaluation of joint swelling as a marker of inflammation.
  • Analysis of inflammatory cytokine levels to gauge immune response activity.
  • Assessment of extracellular matrix degradation markers indicating cartilage breakdown.
  • Histopathological examination of liver and kidney tissues to ensure treatments did not cause systemic toxicity.

Key Results

• Functional Improvement:
  • Reduction in pain-related behaviors was observed in rats treated with PRP and CCP compared to untreated OA controls, indicating effective pain relief.
  • Joint swelling was alleviated, signifying reduced inflammation in treated animals.
• Cartilage Protection:
  • Gross morphology and histopathology showed diminished cartilage damage in treated groups, suggesting protective effects on joint tissues.
  • Standardized scoring systems reflected less severe cartilage degeneration after combined treatment.
• Inflammatory and Cartilage Degradation Markers:
  • Levels of inflammatory cytokines decreased, highlighting an anti-inflammatory effect of the therapy.
  • Markers related to breakdown of the extracellular matrix were reduced, indicating slowed cartilage degradation.
• Safety:
  • Histopathological evaluations of liver and kidney tissues revealed no abnormalities, suggesting the combined PRP and CCP treatment is safe without apparent organ toxicity.

Conclusions and Implications

• The combination of PRP and CCP injections effectively reduces inflammation, relieves pain, and protects cartilage in a rat model of post-traumatic OA.
• This combined therapy shows promise as a potential treatment strategy to improve joint function and slow disease progression in OA patients following joint injury.
• Findings support further investigation into the clinical application of PRP and CCP for osteoarthritis, possibly paving the way for new regenerative and anti-inflammatory therapies.
• Importantly, no apparent systemic toxicity was observed, indicating that this treatment could be safe for further development.

Summary

• The study provides valuable experimental evidence that combined PRP and CCP injections help manage symptoms and underlying pathological changes in post-traumatic OA.
• By addressing both inflammation and cartilage degradation, this therapeutic approach could fill a significant gap in osteoarthritis management, focusing not only on symptom relief but also tissue preservation.